$4.6 Billion Breast Imaging Market by Technology (Ionizing & Non-ionizing) - Worldwide Forecast to 2023 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Feb 4, 2019--The “Breast Imaging Market by Technology (Ionizing (Mammography (Digital Mammography, 3D Mammogram, Analog), MBI, PET-CT, PEM), Non-ionizing (Breast Ultrasound, Breast MRI, Automated Whole-Breast Ultrasound, Breast Thermography) - Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.
The global breast imaging market is projected to reach USD 4.6 billion by 2023 from USD 3.1 billion in 2018, at a CAGR of 8%.
Growth in this market is largely driven by factors such as the rising prevalence of breast cancer, growth in the geriatric population (as age contributes to the risk of breast cancer) and changing lifestyles, which have increased the overall possibility of cancer occurrence.
However, errors in screening and misdiagnosis, the side-effects of radiation exposure, and the growing adoption of refurbished imaging systems are the major factors that are expected to restrain the growth of this market during the forecast period.
The ionizing breast imaging segment is expected to account for the largest market share during the forecast period
Based on technology, the breast imaging market is segmented into ionizing (mammography, PET-CT, MBI, and PEM), non-ionizing (breast ultrasound, breast MRI, AWBU, and breast thermography), and other breast imaging technologies (CBCT, electrical impedance tomography, and optical imaging).
The ionizing breast imaging segment accounted for the largest share of this market in 2018, driven by the technological advancements in ionizing breast imaging technologies and rising awareness about the early screening and diagnosis of breast cancer.
The molecular breast imaging (MBI) segment to witness second-highest growth in the ionizing breast imaging market during the forecast period
Based on type, the ionizing breast imaging technology market is segmented into mammography, PET-CT, MBI, and PEM. The MBI segment is expected to witness the second-highest growth rate in the market during the forecast period.
The MBI technique is simple, fast, and highly sensitive and can be used for patients who are claustrophobic or allergic to gadolinium, which are the key factors driving its adoption in the breast imaging market.
Europe to account for the second-largest share of the global market in 2018
The breast imaging market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. Europe accounted for the second-largest share of the global breast imaging market in 2018.
The increasing number of regulatory approvals for advanced breast imaging modalities, growing number of distribution collaborations and partnerships among market players, and the implementation of various awareness programs by several European organizations are the major factors propelling the demand for breast imaging in Europe.
DriversGrowing Incidence of Breast Cancer Increasing Public-Private Investments, Funds and Grants Increasing Awareness on Early Detection of Breast Cancer Growth in the Aging Population
RestraintsHigh Cost of Breast Imaging Systems Unfavorable Reimbursement Scenario
OpportunitiesEmerging Economies Offer High Growth Potential Miniaturization and Technological Advancements
ChallengesSide-Effects of Radiation Exposure Errors in Breast Cancer Screening and Diagnosis Risk of Overdiagnosis and Patient Anxiety Increasing Adoption of Refurbished Imaging Systems
TrendsArtificial Intelligence Personalized Approach to Breast Cancer Screening
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Research Data
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Research Limitations and Assumptions
3 Executive Summary
4 Premium Insights
4.1 Breast Imaging: Market Overview
4.2 Technology Analysis - Breast Imaging Market, By Region
4.3 Asia Pacific Mammography Market, By Type and Country
4.4 European Ionizing Breast Imaging Market, By Type and Country
4.5 Non-Ionizing Breast Imaging Market, By Type
4.6 Geographic Snapshot of the Breast Imaging Market
5 Market Overview
5.2 Market Dynamics
5.3 Market Trends
5.4 Screening Guidelines for Breast Cancer
5.5 Pricing Analysis
6 Breast Imaging Market, By Technology
6.2 Ionizing Breast Imaging Technologies
6.3 Non-Ionizing Breast Imaging Technologies
6.4 Other Breast Imaging Technologies
6.5 Cad Software
7 Breast Imaging Market, By Region
7.2 North America
7.4 Asia Pacific
7.5 Rest of the World
8 Competitive Landscape
8.2 Competitive Leadership Mapping (Overall Market)
8.3 Vendor Inclusion Criteria
8.4 Vendor Dive
8.5 Competitive Leadership Mapping (Smse/Start-Up)
8.6 Market Share Analysis, By Modality
8.7 Competitive Scenario
9 Company Profiles
9.1 Hologic, Inc.
9.2 GE Healthcare (A Part of General Electric Company)
9.3 Siemens Healthineers (A Part of Siemens AG)
9.4 Philips Healthcare (A Part of Koninklijke Philips N.V.)
9.5 Aurora Imaging Technology, Inc.
9.6 Canon Inc.
9.7 CMR Naviscan
9.8 Delphinus Medical Technologies, Inc.
9.9 Dilon Technologies, Inc.
9.10 Fujifilm Holdings Corporation
9.11 Kub Technologies
9.12 Micrima Limited
9.13 Planmed Oy
9.14 Sonocin, Inc.
9.15 Supersonic Imagine
For more information about this report visit https://www.researchandmarkets.com/research/xbfvzl/4_6_billion?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190204005379/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES ONCOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 02/04/2019 08:07 AM/DISC: 02/04/2019 08:07 AM